TheNewsRoom | MELA Sciences Rises 20.5% on Amendment to MelaFind Premarket

All of these words:

The exact phrase:

None of these words:

Categories

Date

Providers

Advanced Search

Learn More

Grab Networks has a huge collection of videos from over 300 news sources. Find in-depth news, embed it to your site, and build community!

About Us
Embedding
Getting Paid
Updates

Connect

The Gallery

Bookmark

MELA Sciences Rises 20.5% on Amendment to MelaFind Premarket

March 02, 2011

MELA Sciences (MELA) is up after it says it filed an amendment to the premarket approval application of MelaFind, its skin-cancer detecting device with the FDA. The amendment clarifies the intended use of MelaFind to dermatologists as a response to public statements made by several dermatologists sitting on the MelaFind FDA Advisory Panel.